Clinical Application of CAR T Cells is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held from Mar 14 - 15, 2019 at Memorial Sloan Kettering Cancer Center - Zuckerman Research Center, New York City, New York, United States of America.
The target audience for this medical event is medical oncologists and oncology fellows in training, basic scientists, research fellows in training, nurses, clinical trial research staff, immunologists, and surgeons with an interest in tumor immunology and immunotherapy.
Chimeric antigen receptor (CAR) T-cell ("Living Drug") immunotherapy is showing promising results in the treatment of cancers. There are nine ongoing clinical trials (Phase I & II) at Memorial Sloan Kettering (MSK) and more are on track to be initiated next year. Over the years, MSK has accumulated a breadth of knowledge about developing and translating these clinical trials from bench to bedside – choosing the ideal antigen target, constructing clinical grade CARs and vectors, investigating CARs in clinically relevant models, manufacturing, quality control, developing protocols for FDA approval, optimizing consent forms that cover emerging ethical issues, managing complications, and conducting world-class correlative science.
MSK faculty, along with national and international experts, will discuss the clinical and translational aspects of cell therapies (CARs, TCRs, NKs), both for hematologic malignancies and solid tumors.
Main Sessions Topics:
• Building your own CAR T-cell program
• Mechanisms of Relapse in CD19 CAR T-cell therapies
• Beyond CD19 for hematological malignancies
• Solid tumor cell therapy clinical trials
• Novel gene engineering in cell therapies
• National guidelines for adoptive cell therapy
• Toxicity management in clinic
• Manufacturing processes for cell engineering
• Off-the shelf cell therapies
• Navigating the IP and licensing landscape
Breakout Session Topics:
• Operational infrastructure of commercial cell therapies
• Novel assays for cell therapy monitoring
• Vectors and tools for gene engineering
• Meet the experts session
• Roundtable Discussion Forums
• ABC of Cell Therapy for paramedical staff
• To learn new developments in CAR T-cell therapy
• To learn patient toxicity management
• To learn patient clinical trial management algorithms
*Early Registration - Apply promo code CARTC19E at checkout (deadline: January 31, 2019)
Physicians (MDs, PhDs and DOs) - $500
Residents, Fellows, Nurses and Other Healthcare Providers - $200
|Registration Type||End Date||Price|
|Physicians (MDs, PhDs and DOs)||15 Mar,2019||USD 600.00|
|Residents, Fellows, Nurses and Other Healthcare Providers||15 Mar,2019||USD 300.00|
|All Members (any employee working for a commercial interest**)||15 Mar,2019||USD 1500.00|